Media Mentions on Regulatory Research & Real-World Data Insights

View Media Mentions

Computer-Aided Clinical Trials for Medical Devices: From Research to Reality

Melanie Ivarsson – Scientific Advisory Board Member, PhaseV

Melanie Ivarsson – Scientific Advisory Board Member, PhaseV PhaseV CEO: Now is the Time to Embrace AI for Clinical Trial Success

5th Annual BioTech Breakthrough Awards Program Honors World’s Most Innovative Life Sciences and Biotechnology Companies

Meet the AI Disruptors 60: The Startups Defining AI’s Future

Digital Health 50: The most promising digital health startups of 2025

As Pricing Pressures Mount, Biopharma Turns To AI To Reduce Trial Failure Rates

Bioforum becomes latest CRO to deploy PhaseV’s AI trial design tech

PhaseV and Bioforum partner to enhance clinical trials with AI/ML

PhaseV and Bioforum partner to enhance clinical trials with AI/ML

PhaseV Announces New ClinOps AI Platform: Transforming Clinical Trial Operations with Precision-Guided Site Selection

PhaseV and Crohn’s & Colitis Foundation join forces to fast-track IBD clinical trials with AI

European biotech: trends to watch in 2025

CROs must embrace AI says PhaseV, following $50m funding round to expand platform

PhaseV raises $50M for AI platform to enhance clinical trials

Supercharging AI for Clinical Development: Our Investment in Phase

Exclusive: PhaseV raises $50M Series A to optimize clinical development

New partnership between PhaseV and Crohn’s & Colitis Foundation leverages AI and RWD to transform IBD trials

PhaseV and Alimentiv to support execution of adaptive clinical trials for GI

GI-focused CRO Alimentiv ups trial tech with PhaseV’s adaptive machine learning software

Seven new drug discovery deals powered by AI

PhaseV Advances Machine Learning-Driven Lupus Research in New Toronto Collaboration

Seven Top Pharma Companies Adopt PhaseV's Machine Learning Technology for Drug Development

Seven Top Pharma Companies Adopt PhaseV's Machine Learning Technology for Drug Development

How A.I. Is Disrupting Pharma: The High-Stakes Race to Revolutionize Drug Discovery

PhaseV Appoints Hamza Sheikh as Head of Business Development

PhaseV Unveils Machine Learning-Powered Platform to Improve Oncology Clinical Trials - BioQuick News

Marks: FDA Struggles To Keep Up With Innovation In Gene Editing, AI

ML could facilitate increased adoption of adaptive clinical trials - Drug Discovery World (DDW)

DIA 2024: Machine Learning and Simulations to Facilitate Clinical Trials

POS1014 USE OF AN INTERACTIVE ADAPTIVE-TRIAL AI SIMULATION TOOL

Machine learning drafted to aid Phase 3 testing of ALS therapy PrimeC

NeuroSense taps PhaseV’s ML tech for Phase III ALS trial analysis

Quanticate and PhaseV partner on new adaptive clinical trial service

New ML-Powered Solution to Increase Success Rates of Phase 3 Oncology Trials - European Pharmaceutical Manufacturer

PhaseV and Quanticate partner to help sponsors run more adaptive trialsPhaseV and iOMEDICO Partner to Launch New ML-Powered Solution to Increase Success Rates of Phase 3 Oncology Trials | BioSpace

Sustainability challenges in rare disease trials remain, but change is happening

9xchange Biopharma Marketplace Partners with PhaseV to Bring ML-Powered Clinical Trial Optimization Technology to Ecosystem Members

PhaseV raise $15m for ML technology to optimise trial design

PhaseV reaps $15M in funding to streamline trial design with machine learning